Skip to main

Impact case study database

The impact case study database allows you to browse and search for impact case studies submitted to the REF 2021. Use the search and filters below to find the impact case studies you are looking for.
Impact case study database FAQs
Download all impact case studies (spreadsheet)
Download all impact case studies (spreadsheet) (generating)
Download all impact case study tags (spreadsheet)
Download all impact case study tags (spreadsheet) (generating)
Back

Endocrine therapy in breast cancer treatment

Download case study PDF
Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Summary impact type
Health
Request cross-referral to
-
Is this case study continued from a case study submitted in 2014?
No
Underpinning research subjects
  • Clinical Sciences
  • Oncology And Carcinogenesis
  • Public Health And Health Services

1. Summary of the impact

2. Underpinning research

3. References to the research

4. Details of the impact

5. Sources to corroborate the impact

Additional contextual information

Grant funding

Grant number Value of grant
BBC024X (internal) £30,872,915
None given (BRC 2007) £46,800,000
CTR-Q3-Y2 £23,200,000
C569/10404 £0
CTR-Q4 £39,327,814
C569/A16891 £0
KG080081 £0
BRC-2011-10059 £61,543,735
IS-BRC-1215-20021 £43,074,315
Countries
  • US
  • UK
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Iceland
  • Liechtenstein
  • Norway
  • Switzerland
  • Canada
  • Israel
  • Australia
  • China
  • New Zealand
Formal partners
  • The Royal Marsden NHS Foundation Trust
  • Queen Mary University of London
  • University College London
  • Pfizer
Funding programmes
  • Breast Cancer Now (previously Breakthrough Breast Cancer) Centre Core Grant 2003 to 2010
  • The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2007)
  • Breast Cancer Now (previously Breakthrough Breast Cancer) Centre Core Grant 2011 to 2015
  • Cancer Research UK grant C569/10404
  • Breast Cancer Now (previously Breakthrough Breast Cancer) Centre Core Grant 2015 to 2021
  • Cancer Research UK grant C569/A16891
  • Susan G. Komen: Cure Promise Grant
  • The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2012)
  • The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2017)
Global research identifiers
  • grid.458394.7
  • grid.451056.3
  • grid.11485.39
  • grid.428834.1
Name of funders
  • Breakthrough Breast Cancer (now Breast Cancer Now)
  • National Institute for Health Research
  • Cancer Research UK
  • Susan G. Komen
Researcher ORCIDs
  • 0000-0003-4122-744X
  • 0000-0001-8937-0873
  • 0000-0001-7957-7424
  • 0000-0001-5718-2501
  • 0000-0002-9072-2749